Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by mollevi
Group name EquipeNB
Item Type Note
Note The following values have no corresponding Zotero field:
auth-address: CIRI, Universite de Lyon, France; INSERM, U1111, Ecole Normale Superieure de Lyon, Lyon, France. CDithem. Faculte de Pharmacie, Lille, France; www.CDithem.com Universite Paris Diderot, Sorbonne Paris Cite, Molecules Therapeutiques in silico, France INSERM UMR-S 973, Paris Cedex 13, France. CDithem. Faculte de Pharmacie, Lille, France; www.CDithem.com INSERM U761, Biostructures and Drug Discovery, Universite de Lille, Institut Pasteur de Lille, IFR 142, PRIM, Lille, France. IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier1; Institut Regional du Cancer de Montpellier, Montpellier, France. Universite Paris Diderot, Sorbonne Paris Cite, Molecules Therapeutiques in silico, France INSERM UMR-S 973, Paris Cedex 13, France. Universite Lyon 1, Univ Lyon, CNRS, UMR5086, Bases Moleculaires et Structurales des Systemes Infectieux, France. CIRI, Universite de Lyon, France; INSERM, U1111, Ecole Normale Superieure de Lyon, Lyon, France IRCM, Institut de Recherche en Cancerologie de Montpellier; INSERM, U896; Universite Montpellier1; Institut Regional du Cancer de Montpellier, Montpellier, France. CDithem. Faculte de Pharmacie, Lille, France; www.CDithem.com INSERM U761, Biostructures and Drug Discovery, Universite de Lille, Institut Pasteur de Lille, IFR 142, PRIM, Lille, France benoit.deprez@univ-lille2.fr bruno.villoutreix@inserm.fr nathalie.bonnefoy@inserm.fr florence.leroux@pasteur-lille.fr.
alt-title: Journal of biomolecular screening
number: 7
accession-num: 24809353
Tags _EndnoteXML import
Date Added 2018/11/14 - 12:04:32
Date Modified 2018/11/14 - 12:04:32
Parent item Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés